Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) shares hit a new 52-week high during trading on Friday after HC Wainwright raised their price target on the stock from $190.00 to $200.00. HC ...
Leerink Partnrs lowered their FY2028 earnings per share estimates for Axsome Therapeutics in a research note issued on ...
11h
Investor's Business Daily on MSNThese Biotech Stocks Aren't Profitable But Still Make Elite IBD 50A handful of biotech stocks made an elite list despite being unprofitable. But many show robust sales growth and constructive ...
17hon MSN
Goldman Sachs analysts listed the stocks with the largest increases and decreases in short interest since the U.S. election day. Analysts looked through short interest data reflecting positions as of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results